GlucoCheck
Pain-free Glucose Testing
Health Tech & Life Sciences
Non Active, May 2018 ceased to operate
Company Overview
Snapshot
Founded in December 2012 by Adi Kahn, GlucoCheck operates with 1–10 employees. The company is currently in the Pre-Funding stage and ceased operations in May 2018.
Business overview
GlucoCheck is developing a proprietary, patent-pending solution for self-monitoring of blood glucose (SMBG). The company's core technology focuses on pain-free, alternative-site SMBG designed to meet FDA and medical staff requirements as a permanent replacement for fingertip SMBG. GlucoCheck operates within the Health Tech & Life Sciences sector, specifically targeting the Medical Devices and Medical Monitors categories, serving patients and consumers.
Log in to access full profile ›Company Intelligence Q&A
- What is GlucoCheck's primary focus?
- GlucoCheck is focused on developing a proprietary, patent-pending solution for pain-free, alternative-site self-monitoring of blood glucose (SMBG).
- When was GlucoCheck founded and by whom?
- GlucoCheck was founded in December 2012 by Adi Kahn.
- What is the current status of GlucoCheck?
- GlucoCheck is currently non-active and ceased to operate in May 2018.
- In which sector does GlucoCheck operate?
- GlucoCheck operates within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Monitors.
- What is GlucoCheck's product stage?
- GlucoCheck's product is currently in the R&D stage, developing a proprietary, patent-pending solution for self-monitoring of blood glucose.